Who Gains the Most Cardiovascular Benefits from SGLT2 and GLP-1 Medications?
Recent research shows SGLT2 inhibitors offer cardiovascular benefits for older patients, while GLP-1 agonists are more effective for younger women with diabetes.
Who Gains the Most Cardiovascular Benefits from SGLT2 and GLP-1 Medications? Read More »